Abstract
Increasing evidence indicates the importance of ascertaining the quantitative estrogen receptor (ER) and progesterone receptor (PR) content (in femtomoles per milligram cytosol protein) of primary breast cancers. Those values obtained from the tumors of 1,887 patients participating in National Surgical Adjuvant Breast and Bowel Project protocol B-09 have been analyzed to define (1) the distribution of tumor ER or PR according to patient age, (2) the distribution of tumor PR within a specific ER interval, and (3) the concordance of tumor ER and PR levels. The present findings indicate how predictive the knowledge of the amount of one receptor (e.g., ER) may be for estimating the amount of the other (PR), when the latter is unknown.
Keywords
MedicineConcordanceBreast cancerProgesterone receptorEstrogen receptorInternal medicineEstrogenCancerDistribution (mathematics)OncologyReceptorGynecology
Related Publications
Triple-negative breast cancer molecular subtyping and treatment progress
Triple-negative breast cancer (TNBC), a specific subtype of breast cancer that does not express estrogen receptor (ER), progesterone receptor (PR), or human epidermal growth fac...
Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update
PURPOSE To update key recommendations of the American Society of Clinical Oncology/College of American Pathologists estrogen (ER) and progesterone receptor (PgR) testing in brea...
Localization of Progesterone Receptor with Monoclonal Antibodies to the Human Progestin Receptor*
A series of rat and mouse monoclonal antibodies to the human progesterone receptor (PR) has recently been produced. These antibodies were used for the immunocytochemical identif...
ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67
Abstract Introduction Accurate assessment of estrogen receptor (ER), progesterone receptor (PR), and Ki-67 is essential in the histopathologic diagnostics of breast cancer. Comm...
Incidence and implications of HER2 and hormonal receptor overexpression in newly diagnosed metastatic breast cancer (MBC)
764 Background: Overexpression of the HER2 receptor protein predicts a worse prognosis and higher metastatic risk in patients (pts) with breast cancer. HER2 positivity also has ...
Publication Info
- Year
- 1983
- Type
- article
- Volume
- 1
- Issue
- 6
- Pages
- 349-358
- Citations
- 40
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
40
OpenAlex
Cite This
Bernard Fisher,
D. Lawrence Wickerham,
A Brown
et al.
(1983).
Breast cancer estrogen and progesterone receptor values: their distribution, degree of concordance, and relation to number of positive axillary nodes..
Journal of Clinical Oncology
, 1
(6)
, 349-358.
https://doi.org/10.1200/jco.1983.1.6.349
Identifiers
- DOI
- 10.1200/jco.1983.1.6.349